MAPT and Alzheimer disease: There is no standard approach to diagnose AD and disease presence cannot be determined by a single test but is rather a multi-faceted and multi-disciplinary approach involving taking medical history, cognitive tests, amyloid-PET scans, and sometimes cerebrospinal fluid (CSF) samples for measurement of amyloid-beta or tau [2].